Mydicar

The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
Celladon halves its workforce to conserve cash after gene therapy meltdown
Fierce Biotech
Fri, 05/15/15 - 09:35 am
layoffs
Celladon
gene therapy
Mydicar
Celladon's stock craters after disappointing trial results, downgrade
Marketwatch
Mon, 04/27/15 - 10:01 am
Celladon
heart faliure
Mydicar
Could This Clinical-Stage Biotech Stock Soar in April?
Motley Fool
Thu, 03/12/15 - 11:24 am
Celladon
Mydicar
Celladon's Mydicar candidate granted breakthrough therapy designation by FDA
The Fly on the Wall
Thu, 04/10/14 - 10:39 am
Celladon
Mydicar
breakthrough therapies
FDA
heart failure
Celladon, Xencor bid for $155M in red-hot IPO market
Fierce Biotech
Fri, 10/11/13 - 09:00 am
IPOs
Celladon
Xencor
Mydicar
XmAb
Corporate VCs crowd into $43M round for Celladon
Fierce Biotech
Wed, 02/15/12 - 10:51 am
venture capital
Celladon
Mydicar
heart failure